Crossmark

Successful cefiderocol therapy of severe infections due to difficult-to-treat Pseudomonas aeruginosa in two allogeneic hematopoietic stem cell transplantation recipients

Crossref DOI link: https://doi.org/10.1007/s00277-021-04737-z

Published Online: 2022-01-18

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gras, Julien https://orcid.org/0000-0001-7247-3358
Villar-Fernandez, Sara

Baylac, Pierre

Xhaard, Aliénor

Valade, Sandrine

Camelena, François

Bercot, Béatrice

Touratier, Sophie

de Fontbrune, Flore Sicre

Molina, Jean-Michel

Lafaurie, Matthieu
License Information

Text and Data Mining valid from 2022-01-18

Version of Record valid from 2022-01-18
More Information

Article History

Received: 2 July 2021

Accepted: 7 December 2021

First Online: 18 January 2022

Declarations

:

: All experimental protocols were approved by the ethics committee and the institutional review board of the APHP (Assistance Publique des Hôpitaux de Paris).All methods were carried out in accordance with relevant guidelines and regulations in the declaration section.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below